<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34048688</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>02</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2213-6711</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>6</Issue><PubDate><Year>2021</Year><Month>Jun</Month><Day>08</Day></PubDate></JournalIssue><Title>Stem cell reports</Title><ISOAbbreviation>Stem Cell Reports</ISOAbbreviation></Journal><ArticleTitle>Reduced PHOX2B stability causes axonal growth impairment in motor neurons with TARDBP mutations.</ArticleTitle><Pagination><StartPage>1527</StartPage><EndPage>1541</EndPage><MedlinePgn>1527-1541</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.stemcr.2021.04.021</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2213-6711(21)00216-2</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is an adult-onset incurable motor neuron (MN) disease. The reasons for selective MN vulnerability in ALS are unknown. Axonal pathology is among the earliest signs of ALS. We searched for novel modulatory genes in human MN axon shortening affected by TARDBP mutations. In transcriptome analysis of RNA present in the axon compartment of human-derived induced pluripotent stem cell (iPSC)-derived MNs, PHOX2B (paired-like homeobox protein 2B) showed lower expression in TARDBP mutant axons, which was consistent with axon qPCR and in situ hybridization. PHOX2B mRNA stability was reduced in TARDBP mutant MNs. Furthermore, PHOX2B knockdown reduced neurite length in human MNs. Finally, phox2b knockdown in zebrafish induced short spinal axons and impaired escape response. PHOX2B is known to be highly express in other types of neurons maintained after ALS progression. Collectively, TARDBP mutations induced loss of axonal resilience, which is an important ALS-related phenotype mediated by PHOX2B downregulation.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mitsuzawa</LastName><ForeName>Shio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suzuki</LastName><ForeName>Naoki</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akiyama</LastName><ForeName>Tetsuya</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ishikawa</LastName><ForeName>Mitsuru</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Physiology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sone</LastName><ForeName>Takefumi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Physiology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kawada</LastName><ForeName>Jiro</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Jiksak Bioengineering Inc. 7-7 Shinkawasaki, Saiwai-ku, Kawasaki 212-0032, Japan; Institute of Industrial Science, the University of Tokyo, 4-6-1 Komaba, Meguro-ku, Tokyo 153-8505, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Funayama</LastName><ForeName>Ryo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Cell Proliferation, United Centers for Advanced Research and Translational Medicine, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shirota</LastName><ForeName>Matsuyuki</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Interdisciplinary Medical Science, United Centers for Advanced Research and Translational Medicine, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mitsuhashi</LastName><ForeName>Hiroaki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Applied Biochemistry, School of Engineering, Tokai University, 4-1-1 Kitakaname, Hiratsuka, Kanagawa 259-1292, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morimoto</LastName><ForeName>Satoru</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Physiology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ikeda</LastName><ForeName>Kensuke</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shijo</LastName><ForeName>Tomomi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ohno</LastName><ForeName>Akiyuki</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakamura</LastName><ForeName>Naoko</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ono</LastName><ForeName>Hiroya</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ono</LastName><ForeName>Risako</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osana</LastName><ForeName>Shion</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Biomedical Engineering for Health and Welfare, Graduate School of Biomedical Engineering, Tohoku University, 2-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakagawa</LastName><ForeName>Tadashi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Cell Proliferation, United Centers for Advanced Research and Translational Medicine, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan; Department of Clinical Pharmacology, Faculty of Pharmaceutical Sciences, Sanyo-Onoda City University, 1-1-1 Daigaku-Doori, Sanyo-Onoda, Yamaguchi 756-0884, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nishiyama</LastName><ForeName>Ayumi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Izumi</LastName><ForeName>Rumiko</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaneda</LastName><ForeName>Shohei</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Industrial Science, the University of Tokyo, 4-6-1 Komaba, Meguro-ku, Tokyo 153-8505, Japan; Department of Mechanical Systems Engineering, Faculty of Engineering, Kogakuin University, 1-24-2 Nishishinjuku, Shinjuku-ku, Tokyo, 163-8677, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ikeuchi</LastName><ForeName>Yoshiho</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute of Industrial Science, the University of Tokyo, 4-6-1 Komaba, Meguro-ku, Tokyo 153-8505, Japan; Institute for AI and Beyond, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakayama</LastName><ForeName>Keiko</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Cell Proliferation, United Centers for Advanced Research and Translational Medicine, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fujii</LastName><ForeName>Teruo</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute of Industrial Science, the University of Tokyo, 4-6-1 Komaba, Meguro-ku, Tokyo 153-8505, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Warita</LastName><ForeName>Hitoshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okano</LastName><ForeName>Hideyuki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Physiology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aoki</LastName><ForeName>Masashi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan. Electronic address: aokim@med.tohoku.ac.jp.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Stem Cell Reports</MedlineTA><NlmUniqueID>101611300</NlmUniqueID><ISSNLinking>2213-6711</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018398">Homeodomain Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C109220">NBPhox protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001369" MajorTopicYN="N">Axons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055785" MajorTopicYN="N">Gene Knockdown Techniques</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018398" MajorTopicYN="N">Homeodomain Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="N">Induced Pluripotent Stem Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059467" MajorTopicYN="N">Transcriptome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015027" MajorTopicYN="N">Zebrafish</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">TAR-DNA binding protein (TARDBP)</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis (ALS)</Keyword><Keyword MajorTopicYN="N">human-induced pluripotent stem cell (hiPSC)-derived motor neurons</Keyword><Keyword MajorTopicYN="N">neurite length</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>7</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>4</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>4</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>28</Day><Hour>20</Hour><Minute>10</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34048688</ArticleId><ArticleId IdType="pmc">PMC8190591</ArticleId><ArticleId IdType="doi">10.1016/j.stemcr.2021.04.021</ArticleId><ArticleId IdType="pii">S2213-6711(21)00216-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Akiyama T., Suzuki N., Ishikawa M., Fujimori K., Sone T., Kawada J., Funayama R., Fujishima F., Mitsuzawa S., Ikeda K. Aberrant axon branching via Fos-B dysregulation in FUS-ALS motor neurons. EBioMedicine. 2019;45:362&#x2013;378.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6642224</ArticleId><ArticleId IdType="pubmed">31262712</ArticleId></ArticleIdList></Reference><Reference><Citation>Allodi I., Nijssen J., Benitez J.A., Schweingruber C., Fuchs A., Bonvicini G., Cao M., Kiehn O., Hedlund E. Modeling motor neuron resilience in ALS using stem cells. Stem Cell Reports. 2019;12:1329&#x2013;1341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6565614</ArticleId><ArticleId IdType="pubmed">31080111</ArticleId></ArticleIdList></Reference><Reference><Citation>An D., Fujiki R., Iannitelli D.E., Smerdon J.W., Maity S., Rose M.F., Gelber A., Wanaselja E.K., Yagudayeva I., Lee J.Y. Stem cell-derived cranial and spinal motor neurons reveal proteostatic differences between ALS resistant and sensitive motor neurons. Elife. 2019;8:e44423.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6594754</ArticleId><ArticleId IdType="pubmed">31157617</ArticleId></ArticleIdList></Reference><Reference><Citation>Babin P.J., Goizet C., Raldua D. Zebrafish models of human motor neuron diseases: advantages and limitations. Prog. Neurobiol. 2014;118:36&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">24705136</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E., Baralle F.E. Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9. J.&#xa0;Biol. Chem. 2001;276:36337&#x2013;36343.</Citation><ArticleIdList><ArticleId IdType="pubmed">11470789</ArticleId></ArticleIdList></Reference><Reference><Citation>Cain J.T., Kim D.I., Quast M., Shivega W.G., Patrick R.J., Moser C., Reuter S., Perez M., Myers A., Weimer J.M. Nonsense pathogenic variants in exon 1 of PHOX2B lead to translational reinitiation in congenital central hypoventilation syndrome. Am. J. Med. Genet. A. 2017;173:1200&#x2013;1207.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5397359</ArticleId><ArticleId IdType="pubmed">28371199</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardani S., Di Lascio S., Belperio D., Di Biase E., Ceccherini I., Benfante R., Fornasari D. Desogestrel down-regulates PHOX2B and its target genes in progesterone responsive neuroblastoma cells. Exp. Cell Res. 2018;370:671&#x2013;679.</Citation><ArticleIdList><ArticleId IdType="pubmed">30036539</ArticleId></ArticleIdList></Reference><Reference><Citation>Cargnin F., Flora A., Di Lascio S., Battaglioli E., Longhi R., Clementi F., Fornasari D. PHOX2B regulates its own expression by a transcriptional auto-regulatory mechanism. J.&#xa0;Biol. Chem. 2005;280:37439&#x2013;37448.</Citation><ArticleIdList><ArticleId IdType="pubmed">16144830</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyne A.N., Siddegowda B.B., Estes P.S., Johannesmeyer J., Kovalik T., Daniel S.G., Pearson A., Bowser R., Zarnescu D.C. Futsch/MAP1B mRNA is a translational target of TDP-43 and is neuroprotective in a Drosophila model of amyotrophic lateral sclerosis. J.&#xa0;Neurosci. 2014;34:15962&#x2013;15974.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4244467</ArticleId><ArticleId IdType="pubmed">25429138</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Lascio S., Belperio D., Benfante R., Fornasari D. Alanine expansions associated with congenital central hypoventilation syndrome impair PHOX2B homeodomain-mediated dimerization and nuclear import. J.&#xa0;Biol. Chem. 2016;291:13375&#x2013;13393.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4933246</ArticleId><ArticleId IdType="pubmed">27129232</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Lascio S., Benfante R., Di Zanni E., Cardani S., Adamo A., Fornasari D., Ceccherini I., Bachetti T. Structural and functional differences in PHOX2B frameshift mutations underlie isolated or syndromic congenital central hypoventilation syndrome. Hum. Mutat. 2018;39:219&#x2013;236.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5846889</ArticleId><ArticleId IdType="pubmed">29098737</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebstein S.Y., Yagudayeva I., Shneider N.A. Mutant TDP-43 causes early-stage dose-dependent motor neuron degeneration in a TARDBP knockin mouse model of ALS. Cell Rep. 2019;26:364&#x2013;373.e64.</Citation><ArticleIdList><ArticleId IdType="pubmed">30625319</ArticleId></ArticleIdList></Reference><Reference><Citation>Egawa N., Kitaoka S., Tsukita K., Naitoh M., Takahashi K., Yamamoto T., Adachi F., Kondo T., Okita K., Asaka I. Drug screening for ALS using patient-specific induced pluripotent stem cells. Sci. Transl. Med. 2012;4:145ra104.</Citation><ArticleIdList><ArticleId IdType="pubmed">22855461</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan Y., Chen P., Raza M.U., Szebeni A., Szebeni K., Ordway G.A., Stockmeier C.A., Zhu M.Y. Altered expression of Phox2 transcription factors in the locus coeruleus in major depressive disorder mimicked by chronic stress and corticosterone treatment in&#xa0;vivo and in&#xa0;vitro. Neuroscience. 2018;393:123&#x2013;137.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6246807</ArticleId><ArticleId IdType="pubmed">30315878</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimori K., Ishikawa M., Otomo A., Atsuta N., Nakamura R., Akiyama T., Hadano S., Aoki M., Saya H., Sobue G. Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent. Nat. Med. 2018;24:1579&#x2013;1589.</Citation><ArticleIdList><ArticleId IdType="pubmed">30127392</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimori K., Matsumoto T., Kisa F., Hattori N., Okano H., Akamatsu W. Escape from pluripotency via inhibition of TGF-beta/BMP and activation of wnt signaling accelerates differentiation and aging in hPSC progeny cells. Stem Cell Rep. 2017;9:1675&#x2013;1691.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5831048</ArticleId><ArticleId IdType="pubmed">29107593</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber K., Karch N., Ernsberger U., Goridis C., Unsicker K. The role of Phox2B in chromaffin cell development. Dev. Biol. 2005;279:501&#x2013;508.</Citation><ArticleIdList><ArticleId IdType="pubmed">15733675</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapeli K., Martinez F.J., Yeo G.W. Genetic mutations in RNA-binding proteins and their roles in ALS. Hum. Genet. 2017;136:1193&#x2013;1214.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5602095</ArticleId><ArticleId IdType="pubmed">28762175</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawada J., Kaneda S., Kirihara T., Maroof A., Levi T., Eggan K., Fujii T., Ikeuchi Y. Generation of a motor nerve organoid with human stem cell-derived neurons. Stem Cell Rep. 2017;9:1441&#x2013;1449.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5831012</ArticleId><ArticleId IdType="pubmed">29107592</ArticleId></ArticleIdList></Reference><Reference><Citation>Leventoux N., Morimoto S., Hara K., Nakamura S., Ozawa F., Mitsuzawa S., Akiyama T., Nishiyama A., Suzuki N., Warita H. Generation of an ALS human iPSC line KEIOi001-A from peripheral blood of a Charcot disease-affected patient carrying TARDBP p.N345K heterozygous SNP mutation. Stem Cell Res. 2020;47:101896.</Citation><ArticleIdList><ArticleId IdType="pubmed">32659732</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling S.C., Polymenidou M., Cleveland D.W. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron. 2013;79:416&#x2013;438.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I.R., Bigio E.H., Ince P.G., Geser F., Neumann M., Cairns N.J., Kwong L.K., Forman M.S., Ravits J., Stewart H. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann. Neurol. 2007;61:427&#x2013;434.</Citation><ArticleIdList><ArticleId IdType="pubmed">17469116</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzoni E.O., Mahony S., Closser M., Morrison C.A., Nedelec S., Williams D.J., An D., Gifford D.K., Wichterle H. Synergistic binding of transcription factors to cell-specific enhancers programs motor neuron identity. Nat. Neurosci. 2013;16:1219&#x2013;1227.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3820498</ArticleId><ArticleId IdType="pubmed">23872598</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsuzawa S., Akiyama T., Nishiyama A., Suzuki N., Kato M., Warita H., Izumi R., Osana S., Koyama S., Kato T. TARDBP p.G376D mutation, found in rapid progressive familial ALS, induces mislocalization of TDP-43. eNeurologicalSci. 2018;11:20&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6006914</ArticleId><ArticleId IdType="pubmed">29928714</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagai T., Ibata K., Park E.S., Kubota M., Mikoshiba K., Miyawaki A. A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications. Nat. Biotechnol. 2002;20:87&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">11753368</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagashimada M., Ohta H., Li C., Nakao K., Uesaka T., Brunet J.F., Amiel J., Trochet D., Wakayama T., Enomoto H. Autonomic neurocristopathy-associated mutations in PHOX2B dysregulate Sox10 expression. J.&#xa0;Clin. Invest. 2012;122:3145&#x2013;3158.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3428093</ArticleId><ArticleId IdType="pubmed">22922260</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakano Y., Fujita M., Ogino K., Saint-Amant L., Kinoshita T., Oda Y., Hirata H. Biogenesis of GPI-anchored proteins is essential for surface expression of sodium channels in zebrafish Rohon-Beard neurons to respond to mechanosensory stimulation. Development. 2010;137:1689&#x2013;1698.</Citation><ArticleIdList><ArticleId IdType="pubmed">20392743</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishiyama A., Niihori T., Warita H., Izumi R., Akiyama T., Kato M., Suzuki N., Aoki Y., Aoki M. Comprehensive targeted next-generation sequencing in Japanese familial amyotrophic lateral sclerosis. Neurobiol. Aging. 2017;53:194 e191&#x2013;194 e198.</Citation><ArticleIdList><ArticleId IdType="pubmed">28160950</ArticleId></ArticleIdList></Reference><Reference><Citation>Pattyn A., Morin X., Cremer H., Goridis C., Brunet J.F. The homeobox gene Phox2b is essential for the development of autonomic neural crest derivatives. Nature. 1999;399:366&#x2013;370.</Citation><ArticleIdList><ArticleId IdType="pubmed">10360575</ArticleId></ArticleIdList></Reference><Reference><Citation>Pei D., Luther W., Wang W., Paw B.H., Stewart R.A., George R.E. Distinct neuroblastoma-associated alterations of PHOX2B impair sympathetic neuronal differentiation in zebrafish models. PLoS Genet. 2013;9:e1003533.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3675015</ArticleId><ArticleId IdType="pubmed">23754957</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimojo D., Onodera K., Doi-Torii Y., Ishihara Y., Hattori C., Miwa Y., Tanaka S., Okada R., Ohyama M., Shoji M. Rapid, efficient, and simple motor neuron differentiation from human pluripotent stem cells. Mol. Brain. 2015;8:79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4666063</ArticleId><ArticleId IdType="pubmed">26626025</ArticleId></ArticleIdList></Reference><Reference><Citation>Song M.R., Shirasaki R., Cai C.L., Ruiz E.C., Evans S.M., Lee S.K., Pfaff S.L. T-Box transcription factor Tbx20 regulates a genetic program for cranial motor neuron cell body migration. Development. 2006;133:4945&#x2013;4955.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5851594</ArticleId><ArticleId IdType="pubmed">17119020</ArticleId></ArticleIdList></Reference><Reference><Citation>Stil A., Drapeau P. Neuronal labeling patterns in the spinal cord of adult transgenic zebrafish. Dev. Neurobiol. 2016;76:642&#x2013;660.</Citation><ArticleIdList><ArticleId IdType="pubmed">26408263</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong M.J., Volkening K., Hammond R., Yang W., Strong W., Leystra-Lantz C., Shoesmith C. TDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein. Mol. Cell. Neurosci. 2007;35:320&#x2013;327.</Citation><ArticleIdList><ArticleId IdType="pubmed">17481916</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor A.M., Blurton-Jones M., Rhee S.W., Cribbs D.H., Cotman C.W., Jeon N.L. A microfluidic culture platform for CNS axonal injury, regeneration and transport. Nat. Methods. 2005;2:599&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1558906</ArticleId><ArticleId IdType="pubmed">16094385</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor J.P., Brown R.H., Jr., Cleveland D.W. Decoding ALS: from genes to mechanism. Nature. 2016;539:197&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Telfer W.R., Busta A.S., Bonnemann C.G., Feldman E.L., Dowling J.J. Zebrafish models of collagen VI-related myopathies. Hum. Mol. Genet. 2010;19:2433&#x2013;2444.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2876888</ArticleId><ArticleId IdType="pubmed">20338942</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian F., Yang W., Mordes D.A., Wang J.Y., Salameh J.S., Mok J., Chew J., Sharma A., Leno-Duran E., Suzuki-Uematsu S. Monitoring peripheral nerve degeneration in ALS by label-free stimulated Raman scattering imaging. Nat. Commun. 2016;7:13283.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5095598</ArticleId><ArticleId IdType="pubmed">27796305</ArticleId></ArticleIdList></Reference><Reference><Citation>Tollervey J.R., Curk T., Rogelj B., Briese M., Cereda M., Kayikci M., Konig J., Hortobagyi T., Nishimura A.L., Zupunski V. Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat. Neurosci. 2011;14:452&#x2013;458.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3108889</ArticleId><ArticleId IdType="pubmed">21358640</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijesekera L.C., Leigh P.N. Amyotrophic lateral sclerosis. Orphanet J. Rare Dis. 2009;4:3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2656493</ArticleId><ArticleId IdType="pubmed">19192301</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>